Global Neurologic Disorders Therapeutics Market Analysis 2015-2019 and Forecast 2020-2025

99S3755073
95 Pages
February 2020
Healthcare

Download Sample Get Discount

Snapshot

The global Neurologic Disorders Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neurologic Disorders Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Central Nervous System (CNS)

Peripheral Nervous System (PNS)

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Biogen Inc.

F. Hoffmann-La Roche Ltd.

Johnson & Johnson Services Inc.

Novartis AG

Pfizer Inc.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Paralysis

Muscle Weakness

Poor Coordination

Loss of Sensation

Seizures

Confusion

Pain and Altered Levels of Consciousness

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Contents

1 Industry Overview

1.1 Neurologic Disorders Therapeutics Industry

Figure Neurologic Disorders Therapeutics Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Neurologic Disorders Therapeutics

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Neurologic Disorders Therapeutics

1.2.2 Downstream

Table Application Segment of Neurologic Disorders Therapeutics

Table Global Neurologic Disorders Therapeutics Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Neurologic Disorders Therapeutics Market by Type

3.1 By Type

3.1.1 Central Nervous System (CNS)

Table Major Company List of Central Nervous System (CNS)

3.1.2 Peripheral Nervous System (PNS)

Table Major Company List of Peripheral Nervous System (PNS)

3.2 Market Size

Table Global Neurologic Disorders Therapeutics Market 2015-2019, by Type, in USD Million

Figure Global Neurologic Disorders Therapeutics Market Growth 2015-2019, by Type, in USD Million

Table Global Neurologic Disorders Therapeutics Market 2015-2019, by Type, in Volume

Figure Global Neurologic Disorders Therapeutics Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global Neurologic Disorders Therapeutics Market Forecast 2020-2025, by Type, in USD Million

Table Global Neurologic Disorders Therapeutics Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 Biogen Inc. (Company Profile, Sales Data etc.)

4.1.1 Biogen Inc. Profile

Table Biogen Inc. Overview List

4.1.2 Biogen Inc. Products & Services

4.1.3 Biogen Inc. Business Operation Conditions

Table Business Operation of Biogen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)

4.2.1 F. Hoffmann-La Roche Ltd. Profile

Table F. Hoffmann-La Roche Ltd. Overview List

4.2.2 F. Hoffmann-La Roche Ltd. Products & Services

4.2.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions

Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Johnson & Johnson Services Inc. (Company Profile, Sales Data etc.)

4.3.1 Johnson & Johnson Services Inc. Profile

Table Johnson & Johnson Services Inc. Overview List

4.3.2 Johnson & Johnson Services Inc. Products & Services

4.3.3 Johnson & Johnson Services Inc. Business Operation Conditions

Table Business Operation of Johnson & Johnson Services Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Novartis AG (Company Profile, Sales Data etc.)

4.4.1 Novartis AG Profile

Table Novartis AG Overview List

4.4.2 Novartis AG Products & Services

4.4.3 Novartis AG Business Operation Conditions

Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Pfizer Inc. (Company Profile, Sales Data etc.)

4.5.1 Pfizer Inc. Profile

Table Pfizer Inc. Overview List

4.5.2 Pfizer Inc. Products & Services

4.5.3 Pfizer Inc. Business Operation Conditions

Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Neurologic Disorders Therapeutics Sales Revenue 2015-2019, by Company, in USD Million

Table Global Neurologic Disorders Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Neurologic Disorders Therapeutics Sales Revenue Share in 2019, by Company, in USD Million

Table Global Neurologic Disorders Therapeutics Sales Volume 2015-2019, by Company, in Volume

Table Global Neurologic Disorders Therapeutics Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Neurologic Disorders Therapeutics Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America Neurologic Disorders Therapeutics Market Concentration, in 2019

Figure Europe Neurologic Disorders Therapeutics Market Market Concentration, in 2019

Figure Asia-Pacific Neurologic Disorders Therapeutics MMarket Concentration, in 2019

Figure South America Neurologic Disorders Therapeutics Market Concentration, in 2019

Figure Middle East & Africa Neurologic Disorders Therapeutics Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Paralysis

Figure Neurologic Disorders Therapeutics Demand in Paralysis, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Paralysis, 2015-2019, in Volume

6.1.2 Demand in Muscle Weakness

Figure Neurologic Disorders Therapeutics Demand in Muscle Weakness, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Muscle Weakness, 2015-2019, in Volume

6.1.3 Demand in Poor Coordination

Figure Neurologic Disorders Therapeutics Demand in Poor Coordination, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Poor Coordination, 2015-2019, in Volume

6.1.4 Demand in Loss of Sensation

Figure Neurologic Disorders Therapeutics Demand in Loss of Sensation, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Loss of Sensation, 2015-2019, in Volume

6.1.5 Demand in Seizures

Figure Neurologic Disorders Therapeutics Demand in Seizures, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Seizures, 2015-2019, in Volume

6.1.6 Demand in Confusion

Figure Neurologic Disorders Therapeutics Demand in Confusion, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Confusion, 2015-2019, in Volume

6.1.7 Demand in Pain and Altered Levels of Consciousness

Figure Neurologic Disorders Therapeutics Demand in Pain and Altered Levels of Consciousness, 2015-2019, in USD Million

Figure Neurologic Disorders Therapeutics Demand in Pain and Altered Levels of Consciousness, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Neurologic Disorders Therapeutics Demand Forecast 2020-2025, by Application, in USD Million

Figure Neurologic Disorders Therapeutics Market Growth 2020-2025, by Application, in USD Million

Figure Neurologic Disorders Therapeutics Market Share in 2025, by Application, in USD Million

Table Neurologic Disorders Therapeutics Demand Forecast 2020-2025, by Application, in Volume

Table Neurologic Disorders Therapeutics Market Growth 2020-2025, by Application, in Volume

Table Neurologic Disorders Therapeutics Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table Neurologic Disorders Therapeutics Production 2015-2019, by Region, in USD Million

Table Neurologic Disorders Therapeutics Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global Neurologic Disorders Therapeutics Market 2015-2019, by Region, in USD Million

Table Global Neurologic Disorders Therapeutics Market Share 2015-2019, by Region, in USD Million

Table Global Neurologic Disorders Therapeutics Market 2015-2019, by Region, in Volume

Table Global Neurologic Disorders Therapeutics Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in USD Million

Figure North America Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in USD Million

Table North America Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in USD Million

Figure Europe Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in USD Million

Table Europe Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in USD Million

Figure South America Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in USD Million

Table South America Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Neurologic Disorders Therapeutics Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Neurologic Disorders Therapeutics Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Neurologic Disorders Therapeutics Market Forecast 2020-2025, by Region, in USD Million

Table Neurologic Disorders Therapeutics Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table